BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 9, 2015
View Archived Issues
Foamix reports topline results from phase II study of FDX-104
Read More
bluebird bio and ViroMed collaborate to develop CAR T-cell therapies
Read More
Athlete receives Zilosul for bone marrow edema under TGA Special Access Scheme
Read More
Merck & Co. reveals strategy to develop biosimilars in Canadian market
Read More
New trial evaluates use of stem cells to treat Alzheimer's disease
Read More
Cynata and Regience sign letter of intent for Cymerus alliance in Japan
Read More
Amgen and Merck & Co. form cancer immunotherapy collaboration
Read More
Samumed reports preliminary efficacy data from phase II study of SM-04554 for androgenetic alopecia
Read More
Tagging AR for degradation shows promise for prostate cancer
Read More
ADC Therapeutics cleared to start phase I trial of ADCT-402
Read More
Preclinical results for anticancer ADC and antibodies
Read More
Evofosfamide fails to increase overall survival in phase III trials
Read More
Johnson & Johnson acquires Novira Therapeutics
Read More
Midatech Pharma acquires DARA BioSciences
Read More
Novel neprilysin inhibitors exhibit good renal profile
Read More
Abcodia's ROCA test available in select U.S. states
Read More
University of Pennsylvania patents rAAV expressing dual antibody constructs
Read More
Roche discloses HER3/HER2 bispecific antibodies
Read More
Immunotope presents DENV universal vaccine candidates
Read More
Theravance initiates first-in-human study of NEP inhibitor TD-0714
Read More
EMA accepts MAA for Sandoz's etanercept biosimilar
Read More
Baxalta's Vonvendi is first FDA-approved recombinant von Willebrand factor
Read More
First clinical results show feasibility of first-in-class HGF/VEGF inhibitor MP-0250 in oncology
Read More
FDA approves Kanuma as first therapy for patients with lysosomal acid lipase deficiency
Read More
IL-15N72D/IL-15Ralpha-Fc superagonist complex shows promise for high-risk hematologic malignancies
Read More
Luspatercept receives FDA fast track designation for anemia in lower-risk MDS
Read More
FDA grants breakthrough therapy designation to Kite's KTE-C19
Read More
Sunesis files MAA for vosaroxin for AML in older adults
Read More
